Saturday, May 16, 2020 9:18:53 PM
marjac, has to be a responsibility of professional integrity clause on the ability of a judge to perform their duties. As someone presiding over a court wouldn't "mental" capacities to perform ones duties be of the utmost importance? I mean, would you want a surgeon performing surgery on you if you knew he just lost a child and was an emotional wreck? All sorts of legal ramifications on this aspect of one's mental state while performing their job. Heck, there are legal ramifications and defenses set up based on what one's mental state of mind are in relation to their actions I would say. I'll leave the technicalities to your more legal mind. All I know is, I agree, unseemly or not, it is a legitimate concern on her state of mind when ruling, or forming the basis for that ruling. She could have been in "a fog" for months on end trying to function properly and putting on her "game" face every day. Who knows? Someone does. Her clerks, family, someone knows what her frame of mind was during all this.
I mean, here is a fighter (see link) that went "into a dark state of mind" after the death of his step-daughter, and is just now 6 to 8 months later returning to the ring. Makes one wonder if Du was in a "dark state of mind" during the AMRN patent trial. How did it affect her? Did it make her less diligent in the performance of her duties? If so, then unseemly or not, this needs looked into. There are several stages one goes through when grieving. What stage was she in when ruling on AMRN case?
https://www.cnn.com/2020/05/15/us/ufc-walt-harris-aniah-blanchard/index.html
I mean, here is a fighter (see link) that went "into a dark state of mind" after the death of his step-daughter, and is just now 6 to 8 months later returning to the ring. Makes one wonder if Du was in a "dark state of mind" during the AMRN patent trial. How did it affect her? Did it make her less diligent in the performance of her duties? If so, then unseemly or not, this needs looked into. There are several stages one goes through when grieving. What stage was she in when ruling on AMRN case?
https://www.cnn.com/2020/05/15/us/ufc-walt-harris-aniah-blanchard/index.html
Recent AMRN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026 • GlobeNewswire Inc. • 02/11/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:06 AM
